Efficacy of Sequential High-Dose Doxorubicin and Ifosfamide Compared With Standard-Dose Doxorubicin in Patients With Advanced Soft Tissue Sarcoma: An Open-Label Randomized Phase II Study of the Spanish Group for Research on Sarcomas - Concepedia

Concepedia

Publication | Open Access

Efficacy of Sequential High-Dose Doxorubicin and Ifosfamide Compared With Standard-Dose Doxorubicin in Patients With Advanced Soft Tissue Sarcoma: An Open-Label Randomized Phase II Study of the Spanish Group for Research on Sarcomas

DOI Full Paper Access

73

Citations

16

References

2009

Year

Joan Maurel, Antonio López–Pousa, R. de las Peñas, J. Fra, Javier Martín‐Broto, Josefina Cruz, Antonio Casado, Andrés Poveda, Javier Martínez‐Trufero, Carmen Balañá,

Journal of Clinical Oncology

Abstract

Single-agent doxorubicin remains the standard treatment in fit patients with advanced soft tissue sarcoma.

References

	Year	Citations

Page 1